Matthew Winton - Insider Trading & Ownership

Entity
Individual
Location
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA
Summary
The estimated net worth of Matthew Winton is at least $10.6K dollars as of April 3, 2024. Matthew Winton is the COO of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $10.6K.
All Insider Reports
All Insider Reports

Ownership of Matthew Winton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INZY Inozyme Pharma, Inc. Coo $10.6K Mar 28, 2024

Insider Transactions Reported by Matthew Winton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.